Building a biotech cluster: the MedCity experience

Giovedì 22 novembre 2018 presso la sede di Fondazione Giannino Bassetti si terrà l'incontro dal titolo "Building a biotech cluster: the MedCity experience".
ELIOT FORSTER, presidente del progetto MedCity che promuove le Scienze della Vita nel London/Cambridge/Oxford "Golden Triangle" sarà relatore introdotto dai Professori Vittorio Bellotti e Francesco Svelto, dell'Università di Pavia.

L'incontro si inscrive nella partnership tra l'Università di Pavia e la Fondazione Giannino Bassetti per la discussione pubblica sui temi dell'innovazione responsabile.

22 novembre 2018 ore 18.00 (registrazione 17.45)
Building a biotech cluster: the MedCity experience
Fondazione Giannino Bassetti
via Michele Barozzi 4, Milano [2]

Biographic sketch of Dr Eliot Forster

Dr Forster holds a PhD in neurophysiology from Liverpool University and an Master in Business Administration from Henley Management College. He is Chairman of the MedCity project that promotes the Life Sciences in the London/Cambridge/Oxford "Golden Triangle". He is an Honorary Visiting Professor of the Pharmacology and Physiology Department at the University of Liverpool, a Board member of OSCHR (Office for Strategic Coordination of Health Research) and the National Genomics Board.
Dr Forster brings over 25 years of experience in the pharmaceutical and biotechnology industry, The early part of Dr Forster's career was at GSK and then he went on to hold a number of senior roles in Pfizer where he became Head of Development and Operations for the EU and Asia, a role in which he was responsible for drug development activities across multiple geographies and was involved in bringing several drugs to market.Since leaving Pfizer, Dr Forster's roles have included the Chief Executive Officer of UK-based Creabilis and Immunocore and very recently as Chairman of the Avacta Group.

-------------

Mostra/Nascondi i link citati nell'articolo